Pnc Financial Services Group, Inc. Moderna, Inc. Transaction History

Pnc Financial Services Group, Inc.

$150 Billion
Q2 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 41,235 shares of MRNA stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,235

Previous 36,502 12.97%

Holding current value

$2.71 Million

Previous $3.89 Million 25.89%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$101.21 - $166.61 $479,026 - $788,565	4,733 Added 12.97%	41,235 $4.9 Million
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $820,576 - $1.11 Million	9,612 Added 35.75%	36,502 $3.89 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $56,233 - $84,483	-809 Reduced 2.92%	26,890 $2.67 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $213,066 - $279,808	-2,210 Reduced 7.39%	27,699 $2.86 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $28,914 - $39,169	244 Added 0.82%	29,909 $3.63 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $1.34 Million - $1.94 Million	-9,845 Reduced 24.92%	29,665 $4.56 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $5,682 - $10,081	48 Added 0.12%	39,510 $7.1 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $1.24 Million - $2.04 Million	10,526 Added 36.38%	39,462 $4.67 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $563,043 - $848,868	4,807 Added 19.92%	28,936 $4.13 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $521,268 - $968,876	4,122 Added 20.6%	24,129 $4.16 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $836,888 - $1.37 Million	-3,706 Reduced 15.63%	20,007 $5.08 Million
Q3 2021 Nov 05, 2021	BUY	$221.9 - $484.47 $1.76 Million - $3.85 Million	7,943 Added 50.37%	23,713 $9.13 Million
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $113,541 - $205,372	874 Added 5.87%	15,770 $3.71 Million
Q1 2021 May 07, 2021	SELL	$109.18 - $185.98 $21,836 - $37,196	-200 Reduced 1.32%	14,896 $1.95 Million
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $226,277 - $584,658	3,442 Added 29.53%	15,096 $1.58 Million
Q3 2020 Nov 06, 2020	BUY	$54.34 - $94.85 $37,983 - $66,300	699 Added 6.38%	11,654 $824,000
Q2 2020 Aug 07, 2020	BUY	$29.67 - $80.0 $199,590 - $538,160	6,727 Added 159.11%	10,955 $703,000
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $1,262 - $2,242	71 Added 1.71%	4,228 $126,000
Q4 2019 Feb 07, 2020	BUY	$13.93 - $21.28 $24,405 - $37,282	1,752 Added 72.85%	4,157 $81,000
Q3 2019 Nov 08, 2019	BUY	$12.26 - $18.07 $2,353 - $3,469	192 Added 8.68%	2,405 $38,000
Q2 2019 Aug 09, 2019	BUY	$13.7 - $28.34 $30,318 - $62,716	2,213 New	2,213 $0

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Moderna, Inc. Transaction History